Blog

2021: A Look Inside Our Crystal Ball (part two)

Posted by Elizabeth Gargill on Tue, Dec 22, 2020

 

For part two of our Crystal Ball series, we asked a few more of our industry experts to comment on the clinical research landscape and to share their predictions for 2021.

Rob Laurens, Principal, RSG Services

 

Do you think a lot of the travel services rapidly deployed in response to COVID-19 will remain in effect? Will they become part of the standard offering?

Undoubtedly, many of the extraordinary support services deployed as a means to directly respond to the impact of the COVID-19 pandemic on clinical trial participant travel not only will remain available after the distribution and anticipated positive impact of vaccines, but also will be enhanced to serve the needs of a redefined approach and capabilities for clinical trial conduct by sponsors and CROs. 

Read More

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Patient Enrollment, Rob Laurens, Aaron Fleishman, Clinical Trial Patient Travel, Decentralized Trials, Virtual, Hybrid Trials, 2021 Predictions, 2021

Ready, Set, Go Virtual!

Posted by Elizabeth Gargill on Tue, Oct 6, 2020

 

Ready, Set, Go Virtual!

New virtual engagement solutions are delivering patients the convenience and immediacy they want in their healthcare experience. Solutions that support decentralized or hybrid trials, like BBK’s virtual RSG® Card, are helping to remove some of the barriers to clinical trial participation that patients cite as the most challenging.

As a matter of fact, in BBK's recent Study Voices 2020 survey, patients selected "immediate reimbursement for study-related expenses" as the most important solution influencing their decision to participate in a clinical trial.

Read More

Topics: Patient Engagement, Patient Experience, Study Voices, Patient Reimbursement, RSG Card, Clinical Trial Innovations, Decentralized Trials, Virtual, Stipends

How Clinical Trial Sponsors Are Responding to COVID-19

Posted by David Fleishman on Fri, Jul 24, 2020

 

We recently sat down with BBK’s Director of Accounts David Fleishman to discuss his experience working with clinical trial sponsors during the COVID-19 outbreak. It’s clear from our conversation that many clinical trial sponsors have had to quickly pivot in response to COVID-19 and are now facing the challenge of adapting to a new normal.

 

Read More

Topics: Patient Engagement, Patient Enrollment, COVID-19, David Fleishman, Virtual